{"id":"https://openalex.org/W1568436845","doi":"https://doi.org/10.1016/j.ejps.2015.08.003","title":"In vitro baselining of new pyrrolopyrimidine EGFR-TK inhibitors with Erlotinib","display_name":"In vitro baselining of new pyrrolopyrimidine EGFR-TK inhibitors with Erlotinib","publication_year":2015,"publication_date":"2015-08-18","ids":{"openalex":"https://openalex.org/W1568436845","doi":"https://doi.org/10.1016/j.ejps.2015.08.003","mag":"1568436845","pmid":"https://pubmed.ncbi.nlm.nih.gov/26296860"},"language":"en","primary_location":{"id":"doi:10.1016/j.ejps.2015.08.003","doi":"https://doi.org/10.1016/j.ejps.2015.08.003","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.ejps.2015.08.003","pdf_url":null,"source":{"id":"https://openalex.org/S119477091","display_name":"European Journal of Pharmaceutical Sciences","issn_l":"0928-0987","issn":["0928-0987","1879-0720"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmaceutical Sciences","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066430526","display_name":"Eirik Sundby","orcid":"https://orcid.org/0000-0002-4598-0239","observed_orcids":["https://orcid.org/0000-0002-4598-0239"]},"institutions":[{"id":"https://openalex.org/I4405282649","display_name":"H\u00f8gskolen i S\u00f8r-Tr\u00f8ndelag","ror":"https://ror.org/006w3dn93","country_code":"NO","type":"education","lineage":["https://openalex.org/I204778367","https://openalex.org/I4405282649"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Eirik Sundby","raw_affiliation_strings":["S\u00f8r-Tr\u00f8ndelag University College, E. C. Dahls gt. 2, NO-7004 Trondheim, Norway. Electronic address: Eirik.Sundby@hist.no","S\u00f8r-Tr\u00f8ndelag University College, E.C. Dahls gt. 2, NO-7004 Trondheim, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"S\u00f8r-Tr\u00f8ndelag University College, E. C. Dahls gt. 2, NO-7004 Trondheim, Norway. Electronic address: Eirik.Sundby@hist.no","institution_ids":["https://openalex.org/I4405282649"]},{"raw_affiliation_string":"S\u00f8r-Tr\u00f8ndelag University College, E.C. Dahls gt. 2, NO-7004 Trondheim, Norway","institution_ids":["https://openalex.org/I4405282649"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069201284","display_name":"Jin Han","orcid":"https://orcid.org/0000-0002-9330-5019","observed_orcids":["https://orcid.org/0000-0002-9330-5019"]},"institutions":[{"id":"https://openalex.org/I204778367","display_name":"Norwegian University of Science and Technology","ror":"https://ror.org/05xg72x27","country_code":"NO","type":"education","lineage":["https://openalex.org/I204778367"]},{"id":"https://openalex.org/I4405282649","display_name":"H\u00f8gskolen i S\u00f8r-Tr\u00f8ndelag","ror":"https://ror.org/006w3dn93","country_code":"NO","type":"education","lineage":["https://openalex.org/I204778367","https://openalex.org/I4405282649"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Jin Han","raw_affiliation_strings":["S\u00f8r-Tr\u00f8ndelag University College, E. C. Dahls gt. 2, NO-7004 Trondheim, Norway; Norwegian University of Science and Technology, Department of Chemistry, H\u00f8gskoleringen 5, NO-7491 Trondheim, Norway. Electronic address: Jin.han@chem.ntnu.no","Norwegian University of Science and Technology, Department of Chemistry, H\u00f8gskoleringen 5, NO-7491 Trondheim, Norway","S\u00f8r-Tr\u00f8ndelag University College, E. C. Dahls gt. 2, NO-7004 Trondheim, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"S\u00f8r-Tr\u00f8ndelag University College, E. C. Dahls gt. 2, NO-7004 Trondheim, Norway; Norwegian University of Science and Technology, Department of Chemistry, H\u00f8gskoleringen 5, NO-7491 Trondheim, Norway. Electronic address: Jin.han@chem.ntnu.no","institution_ids":["https://openalex.org/I204778367","https://openalex.org/I4405282649"]},{"raw_affiliation_string":"Norwegian University of Science and Technology, Department of Chemistry, H\u00f8gskoleringen 5, NO-7491 Trondheim, Norway","institution_ids":["https://openalex.org/I204778367"]},{"raw_affiliation_string":"S\u00f8r-Tr\u00f8ndelag University College, E. C. Dahls gt. 2, NO-7004 Trondheim, Norway","institution_ids":["https://openalex.org/I4405282649"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083097109","display_name":"Svein Jacob Kaspersen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I204778367","display_name":"Norwegian University of Science and Technology","ror":"https://ror.org/05xg72x27","country_code":"NO","type":"education","lineage":["https://openalex.org/I204778367"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Svein Jacob Kaspersen","raw_affiliation_strings":["Norwegian University of Science and Technology, Department of Chemistry, H\u00f8gskoleringen 5, NO-7491 Trondheim, Norway. Electronic address: Svein.jacob.kaspersen@chem.ntnu.no","Norwegian University of Science and Technology, Department of Chemistry, H\u00f8gskoleringen 5, NO-7491 Trondheim, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Norwegian University of Science and Technology, Department of Chemistry, H\u00f8gskoleringen 5, NO-7491 Trondheim, Norway. Electronic address: Svein.jacob.kaspersen@chem.ntnu.no","institution_ids":["https://openalex.org/I204778367"]},{"raw_affiliation_string":"Norwegian University of Science and Technology, Department of Chemistry, H\u00f8gskoleringen 5, NO-7491 Trondheim, Norway","institution_ids":["https://openalex.org/I204778367"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5007098021","display_name":"B\u00e5rd Helge Hoff","orcid":"https://orcid.org/0000-0001-7859-7810","observed_orcids":["https://orcid.org/0000-0001-7859-7810"]},"institutions":[{"id":"https://openalex.org/I204778367","display_name":"Norwegian University of Science and Technology","ror":"https://ror.org/05xg72x27","country_code":"NO","type":"education","lineage":["https://openalex.org/I204778367"]}],"countries":["NO"],"is_corresponding":true,"raw_author_name":"B\u00e5rd Helge Hoff","raw_affiliation_strings":["Norwegian University of Science and Technology, Department of Chemistry, H\u00f8gskoleringen 5, NO-7491 Trondheim, Norway. Electronic address: bard.helge.hoff@chem.ntnu.no","Norwegian University of Science and Technology, Department of Chemistry, H\u00f8gskoleringen 5, NO-7491 Trondheim, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Norwegian University of Science and Technology, Department of Chemistry, H\u00f8gskoleringen 5, NO-7491 Trondheim, Norway. Electronic address: bard.helge.hoff@chem.ntnu.no","institution_ids":["https://openalex.org/I204778367"]},{"raw_affiliation_string":"Norwegian University of Science and Technology, Department of Chemistry, H\u00f8gskoleringen 5, NO-7491 Trondheim, Norway","institution_ids":["https://openalex.org/I204778367"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5007098021"],"corresponding_institution_ids":["https://openalex.org/I204778367"],"apc_list":{"value":3070,"currency":"USD","value_usd":3070},"apc_paid":null,"fwci":1.4257,"has_fulltext":false,"cited_by_count":12,"citation_normalized_percentile":{"value":0.81789785,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"80","issue":null,"first_page":"56","last_page":"65"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.7954000234603882,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.7954000234603882,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.05869999900460243,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.051600001752376556,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pyrrolopyrimidine","display_name":"pyrrolopyrimidine","score":0.9259999990463257},{"id":"https://openalex.org/keywords/egfr-tyrosine-kinase-inhibitors","display_name":"EGFR tyrosine kinase inhibitors","score":0.996999979019165},{"id":"https://openalex.org/keywords/erlotinib","display_name":"erlotinib","score":0.8330000042915344},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.8460000157356262},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.734000027179718},{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.9909999966621399},{"id":"https://openalex.org/keywords/adme-profiling","display_name":"ADME profiling","score":0.921999990940094},{"id":"https://openalex.org/keywords/cyp3a4-inhibition","display_name":"CYP3A4 inhibition","score":0.7929999828338623},{"id":"https://openalex.org/keywords/substrate-dependent-inhibition","display_name":"substrate-dependent inhibition","score":0.7620000243186951},{"id":"https://openalex.org/keywords/herg-channel","display_name":"hERG","score":0.597000002861023},{"id":"https://openalex.org/keywords/caco-2-permeability","display_name":"Caco-2 permeability","score":0.7599999904632568},{"id":"https://openalex.org/keywords/p-glycoprotein","display_name":"P-glycoprotein","score":0.7269999980926514},{"id":"https://openalex.org/keywords/abcg2","display_name":"ABCG2","score":0.8140000104904175},{"id":"https://openalex.org/keywords/abc-transporters","display_name":"ABC transporters","score":0.7200000286102295},{"id":"https://openalex.org/keywords/drug-metabolism","display_name":"drug metabolism","score":0.3779999911785126},{"id":"https://openalex.org/keywords/chiral-compounds","display_name":"chiral compounds","score":0.5559999942779541}],"concepts":[{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.8664339780807495},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6983105540275574},{"id":"https://openalex.org/C2777329042","wikidata":"https://www.wikidata.org/wiki/Q420323","display_name":"Lapatinib","level":5,"score":0.6158870458602905},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5377865433692932},{"id":"https://openalex.org/C69366308","wikidata":"https://www.wikidata.org/wiki/Q2272286","display_name":"ADME","level":3,"score":0.5160576701164246},{"id":"https://openalex.org/C109650736","wikidata":"https://www.wikidata.org/wiki/Q424440","display_name":"CYP3A4","level":4,"score":0.513261079788208},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.47681066393852234},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.46643638610839844},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3017885088920593},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2988887429237366},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.24831891059875488},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2475091516971588},{"id":"https://openalex.org/C526171541","wikidata":"https://www.wikidata.org/wiki/Q407693","display_name":"Cytochrome P450","level":3,"score":0.17283234000205994},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.16750863194465637},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.1630832552909851},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.16100889444351196},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.1380215585231781},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069347","descriptor_name":"Erlotinib Hydrochloride","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000069347","descriptor_name":"Erlotinib Hydrochloride","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000069347","descriptor_name":"Erlotinib Hydrochloride","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011758","descriptor_name":"Pyrroles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011758","descriptor_name":"Pyrroles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011758","descriptor_name":"Pyrroles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018938","descriptor_name":"Caco-2 Cells","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018938","descriptor_name":"Caco-2 Cells","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018938","descriptor_name":"Caco-2 Cells","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D065607","descriptor_name":"Cytochrome P-450 Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D065607","descriptor_name":"Cytochrome P-450 Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D065607","descriptor_name":"Cytochrome P-450 Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D066298","descriptor_name":"In Vitro Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066298","descriptor_name":"In Vitro Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066298","descriptor_name":"In Vitro Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.ejps.2015.08.003","doi":"https://doi.org/10.1016/j.ejps.2015.08.003","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.ejps.2015.08.003","pdf_url":null,"source":{"id":"https://openalex.org/S119477091","display_name":"European Journal of Pharmaceutical Sciences","issn_l":"0928-0987","issn":["0928-0987","1879-0720"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmaceutical Sciences","raw_type":"journal-article"},{"id":"pmid:26296860","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26296860","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.8299999833106995,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320311040","display_name":"Norges Teknisk-Naturvitenskapelige Universitet","ror":"https://ror.org/05xg72x27"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":76,"referenced_works":["https://openalex.org/W76063910","https://openalex.org/W622062215","https://openalex.org/W1495762156","https://openalex.org/W1500036797","https://openalex.org/W1581972781","https://openalex.org/W1963482243","https://openalex.org/W1975764972","https://openalex.org/W1979389466","https://openalex.org/W1982044762","https://openalex.org/W1986026085","https://openalex.org/W1987367854","https://openalex.org/W1988142400","https://openalex.org/W1988369030","https://openalex.org/W1988698939","https://openalex.org/W1988976748","https://openalex.org/W1993522242","https://openalex.org/W1997870940","https://openalex.org/W1999886291","https://openalex.org/W2002714857","https://openalex.org/W2004958423","https://openalex.org/W2005202092","https://openalex.org/W2011858503","https://openalex.org/W2015878053","https://openalex.org/W2022971046","https://openalex.org/W2024741431","https://openalex.org/W2035590944","https://openalex.org/W2035721831","https://openalex.org/W2038670745","https://openalex.org/W2039787365","https://openalex.org/W2049058992","https://openalex.org/W2050240006","https://openalex.org/W2050872970","https://openalex.org/W2052853384","https://openalex.org/W2066122607","https://openalex.org/W2066567180","https://openalex.org/W2067282464","https://openalex.org/W2067884089","https://openalex.org/W2072218566","https://openalex.org/W2074166497","https://openalex.org/W2074350030","https://openalex.org/W2076136110","https://openalex.org/W2082183475","https://openalex.org/W2082871870","https://openalex.org/W2083527129","https://openalex.org/W2086896374","https://openalex.org/W2087402693","https://openalex.org/W2090029719","https://openalex.org/W2090148260","https://openalex.org/W2094409040","https://openalex.org/W2099354673","https://openalex.org/W2101439546","https://openalex.org/W2113341349","https://openalex.org/W2114941442","https://openalex.org/W2117909144","https://openalex.org/W2121389240","https://openalex.org/W2122871705","https://openalex.org/W2124967121","https://openalex.org/W2127960972","https://openalex.org/W2139131914","https://openalex.org/W2139519829","https://openalex.org/W2141527855","https://openalex.org/W2150213614","https://openalex.org/W2150525034","https://openalex.org/W2155014490","https://openalex.org/W2157036356","https://openalex.org/W2159459001","https://openalex.org/W2168964329","https://openalex.org/W2236688557","https://openalex.org/W2335707062","https://openalex.org/W2418690536","https://openalex.org/W2491425068","https://openalex.org/W3193354671","https://openalex.org/W4238991694","https://openalex.org/W6672617142","https://openalex.org/W6677471940","https://openalex.org/W7064455166"],"related_works":["https://openalex.org/W2110887292","https://openalex.org/W2391963389","https://openalex.org/W2091157550","https://openalex.org/W4224986373","https://openalex.org/W2048136894","https://openalex.org/W2418580632","https://openalex.org/W2075966869","https://openalex.org/W4385483651","https://openalex.org/W2363922458","https://openalex.org/W4312226959"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2025-10-10T00:00:00"}